Bone graft substitutes in active or suspected infection. Contra-indicated or not?

Injury. 2011 Sep:42 Suppl 2:S82-6. doi: 10.1016/j.injury.2011.06.189. Epub 2011 Jul 16.

Abstract

Treatment of infection in clinical orthopaedic and trauma care is a time consuming and costly endeavour. More than once, it will lead to extraction of implant material and additional surgical interventions. Currently, debridement, implantation of PMMA beads impregnated with antibiotics most often with implant exchange are the gold standard for deep infection treatment. Recently bone graft substitute materials such as calcium phosphate, collagen fleeces and bioglasses have appeared for specific use in infection treatment. Although these materials show great potential, their supporting level of evidence is still limited. This review paper provides an overview of current understanding and therapies for infection treatment and provides concepts for the use of new developed biomaterials in infection treatment. Furthermore, the benefits and risks of using biomaterials in infection treatment are discussed and the level of evidence of a number of new materials is presented.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Biofilms
  • Bone Cements / therapeutic use*
  • Bone Substitutes / adverse effects
  • Bone Substitutes / therapeutic use*
  • Calcium Phosphates / therapeutic use
  • Collagen / therapeutic use
  • Debridement
  • Drug Delivery Systems
  • Humans
  • Polymethyl Methacrylate / administration & dosage
  • Polymethyl Methacrylate / therapeutic use*
  • Prosthesis-Related Infections / drug therapy*
  • Prosthesis-Related Infections / etiology
  • Reoperation

Substances

  • Anti-Bacterial Agents
  • Bone Cements
  • Bone Substitutes
  • Calcium Phosphates
  • Collagen
  • Polymethyl Methacrylate